Quick Answer
Bio Green Med Solution, Inc. reported Cash and Equivalents of $3.50 million for fiscal year 2025.
Bio Green Med Solution, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $3.50M | +11.7% |
| 2024 | $3.14M | -7.1% |
| 2023 | $3.38M | -81.6% |
| 2022 | $18.34M | -49.8% |
| 2021 | $36.56M | +9.4% |
| 2020 | $33.41M | +181.1% |
| 2019 | $11.88M | -32.1% |
| 2018 | $17.50M | -26.8% |
| 2017 | $23.91M | +44.7% |
| 2016 | $16.52M | -19.2% |
| 2015 | $20.44M | -15.5% |
| 2014 | $24.19M | -22.3% |
| 2013 | $31.15M | +89.8% |
| 2012 | $16.41M | -32.9% |
| 2011 | $24.45M | -17.1% |
| 2010 | $29.50M | +156.6% |
| 2009 | $11.49M | -52.5% |
| 2008 | $24.22M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.84M | +28.7% | -10.2% |
| June 30, 2025 | $4.28M | -28.7% | +23.9% |
| March 31, 2025 | $3.45M | +23.3% | +10.0% |
| December 31, 2024 | $3.14M | -7.1% | +5.2% |
| September 30, 2024 | $2.98M | -49.8% | -50.3% |
| June 30, 2024 | $6.00M | -41.0% | +114.4% |
| March 31, 2024 | $2.80M | -75.5% | -17.2% |
| December 31, 2023 | $3.38M | -81.6% | -43.2% |
- Bio Green Med Solution, Inc. showed an increase of +11.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, Bio Green Med Solution, Inc.’s cash and equivalents has declined by 85.5% (from $24.22 million to $3.50 million).
- The most recent figure is from Bio Green Med Solution, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: